Table 5. Number, Crude Rate, ASR and 95% CI of ASR (Per 100 000 Person-Years) for Pancreatic Cancer in Golestan, Iran, 2006‒2019, by Sex and Year .

	Male					Female					Total
Year	Number	Crude Rate	ASR	ASR-L	ASR-U	Number	Crude Rate	ASR	ASR-L	ASR-U	Number	Crude Rate	ASR	ASR-L	ASR-U
2006	16	1.99	2.87	1.4	4.34	5	0.62	1.03	0.11	1.95	21	1.3	1.97	1.09	2.85
2007	21	2.56	3.49	1.94	5.04	6	0.72	0.93	0.17	1.69	27	1.64	2.24	1.38	3.1
2008	17	2.03	3.05	1.54	4.56	11	1.3	1.82	0.7	2.94	28	1.67	2.43	1.49	3.37
2009	17	1.99	2.95	1.5	4.4	11	1.28	1.6	0.62	2.58	28	1.64	2.24	1.38	3.1
2010	20	2.3	3.33	1.82	4.84	15	1.72	2.47	1.18	3.76	35	2.01	2.88	1.9	3.86
2011	17	1.92	2.7	1.37	4.03	16	1.8	2.21	1.09	3.33	33	1.86	2.42	1.56	3.28
2012	23	2.57	3.69	2.12	5.26	17	1.89	2.42	1.24	3.6	40	2.23	3.02	2.06	3.98
2013	24	2.65	3.62	2.11	5.13	15	1.66	2.07	0.99	3.15	39	2.15	2.81	1.91	3.71
2014	31	3.38	4.78	3.04	6.52	19	2.08	2.66	1.44	3.88	50	2.73	3.68	2.64	4.72
2015	21	2.26	2.86	1.59	4.13	22	2.39	2.88	1.66	4.1	43	2.32	2.85	1.97	3.73
2016	32	3.41	4.4	2.81	5.99	18	1.93	2.42	1.28	3.56	50	2.68	3.4	2.44	4.36
2017	32	3.37	4.21	2.72	5.7	21	2.24	2.43	1.37	3.49	53	2.81	3.29	2.39	4.19
2018	41	4.27	5.45	3.73	7.17	17	1.8	2.2	1.14	3.26	58	3.04	3.75	2.77	4.73
2019	37	3.82	4.89	3.26	6.52	18	1.88	2.32	1.24	3.4	55	2.86	3.53	2.57	4.49

ASR-L: Lower CI limit for ASR; ASR-U: Upper CI limit for ASR